Search Catalog
Browse by Topic
What’s New in Gig-Worker Classifications: Exploring Trends and COVID-19 Implications
Securities class action litigation have continuously skyrocketed over the past years. This trend is expected to grow in fiscal year 2020 as companies constantly engage in global expansions making securities markets more seemingly interconnected. With this, companies are encouraged to prepare for significant changes as well as potential risks and pitfalls. Being updated with the trends and recent court decisions to mitigate the possibility of setbacks is essentially recommended.
Trends, Developments, and What Lies Ahead the Securities Class Action Landscape in 2020
Securities class action litigation have continuously skyrocketed over the past years. This trend is expected to grow in fiscal year 2020 as companies constantly engage in global expansions making securities markets more seemingly interconnected. With this, companies are encouraged to prepare for significant changes as well as potential risks and pitfalls. Being updated with the trends and recent court decisions to mitigate the possibility of setbacks is essentially recommended.
Commercial Litigation in 2020: Winning Tips and Strategies
Along with the increasing volume of commercial disputes is the emergence of various issues that continue to reshape the commercial law landscape. In this LIVE Webcast, seasoned litigators Reginald L. Snyder (Taylor English Duma LLP) and Steven Barber (Steptoe & Johnson LLP) will bring the audience to a road beyond the basics of commercial litigation.
A Practical Guide on the New PTAB Trial Practice: What You Should Know and Do
Policy changes continue to reshape trial practice before the Patent Trial and Appeal Board (PTAB). Some of the recent developments include expansion of the PTAB’s discretionary denial power, potential investigation of PTAB denials by the Congress, and judicial review of PTAB decisions following Thryv v. Click-to-Call.
Preference Claims in Bankruptcy Litigation: Statutory Defenses You Must Consider
Preference claims in bankruptcy litigation have long been a subject of concern among creditors. As significant cases continue to refine and expand this legal landscape, litigators must always expect the emergence of new complexities that may reshape how they defend their clients.
Emerging Trends and Developments in Antitrust Merger Enforcement: What Lies Ahead
Challenges to mergers and acquisitions by US antitrust authorities spiked in 2019, with much attention paid to “nascent” competitive problems and vertical mergers. This was capped off by proposed Department of Justice (DOJ) and Federal Trade Commission (FTC) vertical merger guidelines, the first such guidelines issued since 1984. In addition, the DOJ has continued to express concern about merger remedies, leading to the DOJ’s attempt to stop the AT&T-Time Warner combination. The concern about remedies played another role in the court room, as one court engaged in an unprecedented expanded Tunney Act review of a merger consent order offered by the DOJ. And not to be outdone, the Attorney Generals of several states showed their dissatisfaction with the DOJ remedies in the T-Mobile/Sprint consolidation, bringing their own lawsuit to stop the deal.
Combatting Antitrust Misconduct in Government Procurement: Regulatory and Enforcement Developments
In its continued effort to deter anticompetitive conduct and other violations affecting government procurement, the U.S. Department of Justice (DOJ) created the Procurement Collusion Strike Force in 2019. It is comprised of state and federal investigators and prosecutors mandated to investigate and prosecute all types of procurement collusions and other similar misconduct in government purchasing and programs.
Obviousness-Type Double Patenting (ODP): Demystifying Recent Trends and Significant Court Rulings
In the U.S. and Canada, courts have designed the doctrine of obviousness-type double patenting (ODP) to prevent inventors from gaining an unjust extension of their patent rights by obtaining patent on the obvious variants of an invention. By rejecting and invalidating ODP, courts prevent the manipulation of issue dates and patent rights by patentees.
BPCIA Patent Dance: Navigating the Biosimilar Litigation Landscape in 2020
Since the beginning of 2019, the number of biosimilar litigation - particularly those concerning the Biologics Price Competition and Innovation Act (BPCIA) “patent dance” - has drastically increased. One of the notable BCPIA cases that are being closely watched, is Amgen’s legal battle with Novartis’ Sandoz arm over the Enbrel patent, in which the former intends to hold commercial exclusivity for Enbrel until 2029. The legal precedents established in this dispute are expected to impact the biosimilar market as well as the pending and future biosimilar patent lawsuits.
The Knowledge Group Webcasts
Explore over 450+ Live and 3000+ On-demand webcasts of continuing education programs for Lawyers, Accountants, and Technology professionals. Choose the best course for you!
If you can’t find the webcast you’re looking for, send us an email – [email protected]
Don’t miss out on our next live webcast!
Browse our upcoming programs or find the webcast of your choice by searching through our categories and topics. Join us now to see what you are missing!